University of Nottingham Apr 23 2026 A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults living with type 2 diabetes who are treated with basal insulin. Researchers carried out the FreeDM2 trial, which compared the effectiveness of CGM with traditional finger prick of blood glucose monitoring in adults with type 2 diabetes. The findings of the study, published today in The Lancet Diabetes and Endocrinology,